Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro

Delivery strategies of RNA therapeutics to leukocytes

(2022) Dana Tarab-Ravski et al.   JOURNAL OF CONTROLLED RELEASE

Drug delivery systems for RNA therapeutics

(2022) Kalina Paunovska et al.   NATURE REVIEWS GENETICS

CAR T cells produced in vivo to treat cardiac injury

(2022) Joel G. Rurik et al.   SCIENCE

Marginal zone B cells: From housekeeping function to autoimmunity?

(2021) Anna-Karin E. Palm et al.   JOURNAL OF AUTOIMMUNITY

An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory

(2021) Ole A. W. Haabeth et al.   ACS Central Science

Non-liver mRNA Delivery

(2021) David Loughrey et al.   ACCOUNTS OF CHEMICAL RESEARCH

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

(2020) Qiang Cheng et al.   Nature Nanotechnology

Putative role of marginal zone B cells in pathophysiological processes

(2020) Dragan Marinkovic et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis

(2020) Bisera Stepanovska et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes

(2020) Wei-Ting Chang et al.   MOLECULES

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

(2020) Maria L. Guevara et al.   Frontiers in Chemistry

Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy

(2020) Aaron J. Wilk et al.   Blood Advances

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

(2020) Cole J. Batty et al.   ADVANCED DRUG DELIVERY REVIEWS

The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy

(2019) Jessica B. Foster et al.   MOLECULAR THERAPY

Local delivery of OX40L, CD80, and CD86 mRNA kindles global anti-cancer immunity.

(2019) Ole Audun Werner Haabeth et al.   CANCER RESEARCH

Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery

(2019) Nancy L. Benner et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems

(2019) Jihye Yoo et al.   Cancers

Ligand‐Installed Nanocarriers toward Precision Therapy

(2019) Peng Mi et al.   ADVANCED MATERIALS

Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis

(2019) Claudia Volpi et al.   Expert Opinion on Drug Discovery

Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process

(2019) Azadeh Yazdi et al.   JOURNAL OF NEUROSCIENCE RESEARCH

CD177-mediated nanoparticle targeting of human and mouse neutrophils

(2018) Heini M. Miettinen et al.   PLoS One

Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters

(2018) Colin J. McKinlay et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice

(2018) Ole A. W. Haabeth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways

(2018) Alan Baer et al.   Scientific Reports

A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes

(2018) Taro Shimizu et al.   JOURNAL OF IMMUNOLOGY

GalNAc bio-functionalization of nanoparticles assembled by electrostatic interactions improves siRNA targeting to the liver

(2017) Efrat Korin et al.   JOURNAL OF CONTROLLED RELEASE

Altered Marginal Zone B Cell Selection in the Absence of IκBNS

(2017) Monika Ádori et al.   JOURNAL OF IMMUNOLOGY

Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals

(2017) Colin J. McKinlay et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo

(2016) Kevin J. Kauffman et al.   BIOMATERIALS

Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity

(2016) F L Scott et al.   BRITISH JOURNAL OF PHARMACOLOGY

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

(2016) Lena M. Kranz et al.   NATURE

Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation

(2016) Carolina V. Messias et al.   PLoS One

Homeostatic ‘bystander’ proliferation of human peripheral blood B cells in response to polyclonal T-cell stimulationin vitro

(2015) Aleksandra Jasiulewicz et al.   INTERNATIONAL IMMUNOLOGY

Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice

(2014) Faik Imeri et al.   NEUROPHARMACOLOGY

The Spleen in Local and Systemic Regulation of Immunity

(2013) Vincenzo Bronte et al.   IMMUNITY

Galactose-Functionalized Cationic Polycarbonate Diblock Copolymer for Targeted Gene Delivery to Hepatocytes

(2013) Zhan Yuin Ong et al.   MACROMOLECULAR RAPID COMMUNICATIONS

Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies

(2013) Lindsey M. Pujanauski et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

(2010) Jerold Chun et al.   CLINICAL NEUROPHARMACOLOGY

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

(2010) Volker Brinkmann et al.   NATURE REVIEWS DRUG DISCOVERY

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

(2010) Bart R. Anderson et al.   NUCLEIC ACIDS RESEARCH

S1P1 Receptor Signaling Overrides Retention Mediated by Gαi-Coupled Receptors to Promote T Cell Egress

(2008) Trung H.M. Pham et al.   IMMUNITY